What now for Solagran? Now that the directors realise the Russian Ministry of Health is not going to roll over without a full Phase III trial, are the directors trying to prop-up the price ahead of a capital raising?
I'd be wary of the downside here.
- Forums
- ASX - By Stock
- SLA
- ropren fails june approval
ropren fails june approval
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)